News
The antibiotic resistance genes used in genetic ... In another set of experiments, the fate of plasmid DNA was monitored after being fed to mice 5,6. Most DNA was degraded rapidly, but a fraction ...
Michael Baym is a microbiologist and professor at Harvard Medical School who studies antibiotic resistance. This week he lost five federal grants to his lab. Baym joined WBUR's All Things ...
GSK has reported topline results from a phase 3 trial of its novel antibiotic gepotidacin that could spell the end of a decades-long drought in new oral therapies for gonorrhoea. In the EAGLE-1 ...
The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary tract infections (uUTIs) in nearly 30 years, after a priority review.
Alarmone synthesis depletes GTP levels leading to a GTP-dependent switch that controls triggered, spontaneous and antibiotic-induced persister formation in Bacillus subtilis.
May 15, 2025 — A research team has developed and safely delivered a personalized gene editing therapy to treat an infant with a life-threatening, incurable genetic disease. The infant, who was ...
Further BVA research shows that three out of five vets have seen clients who expect antibiotics to treat their pets and found there is still a lack of understanding about responsible antibiotic use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results